全文获取类型
收费全文 | 8884篇 |
免费 | 621篇 |
国内免费 | 390篇 |
专业分类
耳鼻咽喉 | 97篇 |
儿科学 | 109篇 |
妇产科学 | 35篇 |
基础医学 | 1127篇 |
口腔科学 | 188篇 |
临床医学 | 562篇 |
内科学 | 1037篇 |
皮肤病学 | 582篇 |
神经病学 | 1693篇 |
特种医学 | 228篇 |
外科学 | 518篇 |
综合类 | 872篇 |
现状与发展 | 2篇 |
预防医学 | 618篇 |
眼科学 | 249篇 |
药学 | 1323篇 |
1篇 | |
中国医学 | 393篇 |
肿瘤学 | 261篇 |
出版年
2024年 | 10篇 |
2023年 | 183篇 |
2022年 | 242篇 |
2021年 | 393篇 |
2020年 | 356篇 |
2019年 | 320篇 |
2018年 | 286篇 |
2017年 | 286篇 |
2016年 | 327篇 |
2015年 | 329篇 |
2014年 | 517篇 |
2013年 | 601篇 |
2012年 | 482篇 |
2011年 | 552篇 |
2010年 | 463篇 |
2009年 | 431篇 |
2008年 | 422篇 |
2007年 | 389篇 |
2006年 | 383篇 |
2005年 | 309篇 |
2004年 | 228篇 |
2003年 | 225篇 |
2002年 | 181篇 |
2001年 | 185篇 |
2000年 | 156篇 |
1999年 | 138篇 |
1998年 | 117篇 |
1997年 | 118篇 |
1996年 | 110篇 |
1995年 | 90篇 |
1994年 | 88篇 |
1993年 | 72篇 |
1992年 | 77篇 |
1991年 | 75篇 |
1990年 | 45篇 |
1989年 | 67篇 |
1988年 | 61篇 |
1987年 | 60篇 |
1986年 | 74篇 |
1985年 | 66篇 |
1984年 | 75篇 |
1983年 | 45篇 |
1982年 | 55篇 |
1981年 | 49篇 |
1980年 | 47篇 |
1979年 | 31篇 |
1978年 | 26篇 |
1977年 | 14篇 |
1976年 | 16篇 |
1975年 | 7篇 |
排序方式: 共有9895条查询结果,搜索用时 15 毫秒
41.
43.
Joël Jovanovic Xuan Liu Despina Kokona Martin S. Zinkernagel Andreas Ebneter 《Glia》2020,68(3):574-588
The role of microglia in retinal inflammation is still ambiguous. Branch retinal vein occlusion initiates an inflammatory response whereby resident microglia cells are activated. They trigger infiltration of neutrophils that exacerbate blood–retina barrier damage, regulate postischemic inflammation and irreversible loss of neuroretina. Suppression of microglia-mediated inflammation might bear potential for mitigating functional impairment after retinal vein occlusion (RVO). To test this hypothesis, we depleted microglia by PLX5622 (a selective tyrosine kinase inhibitor that targets the colony-stimulating factor-1 receptor) in fractalkine receptor reporter mice (Cx3cr1gfp/+) subjected to various regimens of PLX5622 treatment and experimental RVO. Effectiveness of microglia suppression and retinal outcomes including retinal thickness as well as ganglion cell survival were compared to a control group of mice with experimental vein occlusion only. PLX5622 caused dramatic suppression of microglia. Despite vein occlusion, reappearance of green fluorescent protein positive cells was strongly impeded with continuous PLX5622 treatment and significantly delayed after its cessation. In depleted mice, retinal proinflammatory cytokine signaling was diminished and retinal ganglion cell survival improved by almost 50% compared to nondepleted animals 3 weeks after vein occlusion. Optical coherence tomography suggested delayed retinal degeneration in depleted mice. In summary, findings indicate that suppression of cells bearing the colony-stimulating factor-1 receptor, mainly microglia and monocytes, mitigates ischemic damage and salvages retinal ganglion cells. Blood–retina barrier breakdown seems central in the disease mechanism, and complex interactions between different cell types composing the blood–retina barrier as well as sustained hypoxia might explain why the protective effect was only partial. 相似文献
44.
The gut microbiota plays an important role in the occurrence and development of neuroimmunological diseases. Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system that is characterized by the peripheral production of the disease-specific serum autoantibody aquaporin-4 (AQP4)-IgG. Recently, accumulating evidence has provided insights into the associations of gut microbiota dysbiosis and intestinal mucosal barrier destruction with NMOSD, but the underlying pathogenesis remains unclear. Thus, a microbiota intervention might be a potential therapeutic strategy for NMOSD by regulating the gut microbiota, repairing the intestinal mucosal barrier, and modulating intestinal immunity and peripheral immunity. 相似文献
45.
《Brain & development》2020,42(3):264-269
ObjectiveSome pediatric patients with autoimmune encephalitis (AE) experience sequelae in spite of immunotherapy. In this study, we aimed to evaluate the association of serum matrix metallopeptidase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) levels with the neurological prognosis of AE.MethodsWe retrospectively included 13 patients with AE who had been referred to Saitama Children’s Medical Center from February 2011 to May 2019. We compared serum MMP-9 levels, TIMP-1 levels, and MMP-9/TIMP-1 ratio in the acute period (within 30 days from the onset of AE) and subacute period (30-day period following the acute period). We also compared these biomarker levels between patients with (group A) and without sequelae (group B). Sequelae were evaluated at discharge or the last visit.ResultsGroup A (median age, 7.8 years; range, 5.3–10.7 years) and group B (median age, 13.3 years; range, 11.1–15.4 years) had 6 patients each; 1 patient was excluded because the time of AE onset was unknown. In the acute period, there were no significant differences in MMP-9 levels, TIMP-1 levels, and MMP-9/TIMP-1 ratio between groups A and B. In the subacute period, serum MMP-9/TIMP-1 ratio was higher in group A than in group B (p < 0.01). There were no significant differences in MMP-9 and TIMP-1 levels between groups A and B.ConclusionsPatients with sequelae of AE showed a high MMP-9/TIMP-1 ratio in the subacute period. Our study demonstrates that elevation of serum MMP-9/TIMP-1 ratio in the subacute period may be a predictive factor of sequelae of AE. 相似文献
46.
47.
Objective To investigate the pathogenesis mechanism of radiation esophagitis from the perspective of mucosal regeneration and to determine whether it is associated with TGF-β1/p38MAPKs/FN signaling pathway. Methods The pathological analysis of esophageal specimens was performed by HE staining method. The expression of FN and TGF-β1 genes were observed by real time-PCR method, and the expression of tissue proteins TGF-β1, p38 and FN were detected by Western blot. Results The weights, food intakes and water intakes at the first week after the occurrence of radiation esophagitis were significantly decreased (P<0.05) and recovered at the fourth week. The esophageal mucosa was destructed at the first and second weeks, and the regeneration occurred in the fourth weeks; TGF-β1 and p38MAPK protein expression increased first and then decreased, while FN protein expression decreased first and then increased. Conclusion The TGF-β1/p38MAPK/FN signaling pathway may be involved in the process of mucosal repair. © 2020, CHINA RESEARCH ON PREVENTION AND TREATMENT. All rights reserved. 相似文献
48.
Leila H. Shayegan BA Laura E. Levin MD Eloise R. Galligan MD Anne W. Lucky MD Anna L. Bruckner MD Elena Pope MD Irene Lara-Corrales MD Karen Wiss MD Catherine C. McCuaig MD Maria C. Garzon MD Lawrence F. Eichenfield MD Kristen P. Hook MD John C. Browning MD MBA Lawrence A. Schachner MD Marissa J. Perman MD Leslie Castelo-Soccio MD PhD Moise L. Levy MD Sharon A. Glick MD Kimberly D. Morel MD 《Pediatric dermatology》2020,37(2):326-332
49.
The blood–brain barrier (BBB) tightly controls the molecular exchange between the brain parenchyma and blood. Accumulated evidence from transgenic animal Alzheimer’s disease (AD) models and human AD patients have demonstrated that BBB dysfunction is a major player in AD pathology. In this review, we discuss the role of the BBB in maintaining brain integrity and how this is mediated by crosstalk between BBB-associated cells within the neurovascular unit (NVU). We then discuss the role of the NVU, in particular its endothelial cell, pericyte, and glial cell constituents, in AD pathogenesis. The effect of substances released by the neuroendocrine system in modulating BBB function and AD pathogenesis is also discussed. We perform a systematic review of currently available AD treatments specifically targeting pericytes and BBB glial cells. In summary, this review provides a comprehensive overview of BBB dysfunction in AD and a new perspective on the development of therapeutics for AD. 相似文献
50.
Pinar Eser Ocak Umut Ocak Prativa Sherchan John H. Zhang Jiping Tang 《Journal of neuroscience research》2020,98(1):29-41
Major facilitator superfamily domain-containing protein-2a (Mfsd2a) which was considered as an orphan transporter has recently gained attention for its regulatory role in the maintenance of proper functioning of the blood–brain barrier. Besides the major role of Mfsd2a in maintaining the barrier function, increasing evidence has emerged with regard to the contributions of Mfsd2a to various biological processes such as transport, cell fusion, cell cycle, inflammation and regeneration, managing tumor growth, functioning of other organs with barrier functions or responses to injury. The purpose of this article is to review the different roles of Mfsd2a and its involvement in the physiological and pathophysiological processes primarily in the central nervous system and throughout the mammalian body under the lights of the current literature. 相似文献